These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9477529)

  • 21. Shortened egg reappearance after ivermectin or moxidectin use in horses in the UK.
    Daniels SP; Proudman CJ
    Vet J; 2016 Dec; 218():36-39. PubMed ID: 27938707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shortened strongyle-type egg reappearance periods in naturally infected horses treated with moxidectin and failure of a larvicidal dose of fenbendazole to reduce fecal egg counts.
    Rossano MG; Smith AR; Lyons ET
    Vet Parasitol; 2010 Oct; 173(3-4):349-52. PubMed ID: 20675055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy of moxidectin and ivermectin against hypobiotic and encysted cyathostomes and other equine parasites.
    Xiao L; Herd RP; Majewski GA
    Vet Parasitol; 1994 May; 53(1-2):83-90. PubMed ID: 8091622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyathostome fecal egg count trends in horses treated with moxidectin, ivermectin or fenbendazole.
    Martin-Downum K; Yazwinski T; Tucker C; Fincher M; Ralph J; Hamilton J
    Vet Parasitol; 2001 Oct; 101(1):75-9. PubMed ID: 11587835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The reappearance of strongyle eggs in faeces of horses treated with pyrantel embonate.
    Boersema JH; Borgsteede FH; Eysker M; Saedt I
    Vet Q; 1995 Mar; 17(1):18-20. PubMed ID: 7610552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trial of moxidectin oral gel in horses.
    DiPietro JA; Hutchens DE; Lock TF; Walker K; Paul AJ; Shipley C; Rulli D
    Vet Parasitol; 1997 Oct; 72(2):167-77. PubMed ID: 9404843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Field tests demonstrating reduced activity of ivermectin and moxidectin against small strongyles in horses on 14 farms in Central Kentucky in 2007-2009.
    Lyons ET; Tolliver SC; Collins SS; Ionita M; Kuzmina TA; Rossano M
    Parasitol Res; 2011 Feb; 108(2):355-60. PubMed ID: 20862493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of moxidectin with ivermectin and pyrantel embonate for reduction of faecal egg counts in horses.
    Taylor SM; Kenny J
    Vet Rec; 1995 Nov; 137(20):516-8. PubMed ID: 8588278
    [No Abstract]   [Full Text] [Related]  

  • 29. Time required by different anthelmintics to reach expected efficacy levels in horses infected by strongyles.
    Saes IL; Vera JHS; Fachiolli DF; Yamada PH; Dellaqua JVT; Saes RL; Amarante AFT; Soutello RVG
    Vet Parasitol; 2016 Oct; 229():90-92. PubMed ID: 27809986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probable reason why small strongyle EPG counts are returning "early" after ivermectin treatment of horses on a farm in Central Kentucky.
    Lyons ET; Tolliver SC; Collins SS
    Parasitol Res; 2009 Feb; 104(3):569-74. PubMed ID: 18931857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expulsion of small strongyle nematodes (cyathostomin spp) following deworming of horses on a stud farm in Sweden.
    Osterman Lind E; Eysker M; Nilsson O; Uggla A; Höglund J
    Vet Parasitol; 2003 Aug; 115(4):289-99. PubMed ID: 12944042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative long-term efficacy of ivermectin and moxidectin over winter in Canadian horses treated at removal from pastures for winter housing.
    Elsener J; Villeneuve A
    Can Vet J; 2009 May; 50(5):486-90. PubMed ID: 19436633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective anthelmintic therapy of horses in the Federal states of Bavaria (Germany) and Salzburg (Austria): an investigation into strongyle egg shedding consistency.
    Becher AM; Mahling M; Nielsen MK; Pfister K
    Vet Parasitol; 2010 Jul; 171(1-2):116-22. PubMed ID: 20356680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced efficacy of ivermectin and moxidectin against Parascaris spp. in foals from Argentina.
    Cooper LG; Caffe G; Cerutti J; Nielsen MK; Anziani OS
    Vet Parasitol Reg Stud Reports; 2020 Apr; 20():100388. PubMed ID: 32448542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of drug-resistant cyathostominosis on a breeding farm in central North Carolina.
    Little D; Flowers JR; Hammerberg BH; Gardner SY
    Equine Vet J; 2003 May; 35(3):246-51. PubMed ID: 12755426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The reappearance of eggs in faeces of horses after treatment with ivermectin.
    Borgsteede FH; Boersma JH; Gaasenbeek CP; van der Burg WP
    Vet Q; 1993 Mar; 15(1):24-6. PubMed ID: 8498011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of exclusive use of ivermectin vs alternation of antiparasitic compounds for control of internal parasites of horses.
    Lyons ET; Drudge JH; Tolliver SC; Granstrom DE; Stamper S
    Am J Vet Res; 1992 Jan; 53(1):97-104. PubMed ID: 1539922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of age-clustered pooled faecal samples for monitoring worm control in horses.
    Eysker M; Bakker J; van den Berg M; van Doorn DC; Ploeger HW
    Vet Parasitol; 2008 Feb; 151(2-4):249-55. PubMed ID: 18037244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of moxidectin against cyathostomins.
    Coles G
    Vet Rec; 2009 Jul; 165(3):91-2; author reply 92. PubMed ID: 19617616
    [No Abstract]   [Full Text] [Related]  

  • 40. Field studies indicating reduced activity of ivermectin on small strongyles in horses on a farm in Central Kentucky.
    Lyons ET; Tolliver SC; Ionita M; Lewellen A; Collins SS
    Parasitol Res; 2008 Jun; 103(1):209-15. PubMed ID: 18389281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.